According to the Complaint, Vaxart, Inc. is a clinical-stage company purportedly engaged in the discovery and development of vaccines for a variety of diseases that would be administered orally, rather than by injection.

According to the Complaint, Maxim Integrated Products, Inc. develops innovative analog and mixed-signal products and technologies to make systems smaller and smarter, with enhanced security and increased energy efficiency.

According to the Complaint, Majesco is a global leader of cloud insurance software solutions for insurance business transformation.

According to the Complaint, American Electric Power Company, Inc. is an electric public utility holding company which engages in the generation, transmission, and distribution of electricity for sale to retail and wholesale customers in the United States.

According to the Complaint, OneSpan Inc. was formerly known as VASCO Data Security International, Inc. and changed its name to OneSpan Inc. in May 2018. OneSpan, together with its subsidiaries, designs, develops, and markets digital solutions for identity, security, and business productivity worldwide.

According to the Complaint, Qutoutiao Inc. offers a mobile application called Qutoutiao (which means "fun headlines") that aggregates articles and short videos from professional media and freelancers and presents customized feeds to users. In September 2018, the Company completed its IPO, selling 13.8 million ADSs at $7.00 per share.

According to the Complaint, Baidu, Inc. purports to provide Internet search services in China and internationally. It operates through two segments, one of which is iQIYI. The iQIYI segment provides online entertainment service, including original and licensed content; membership services; and online advertising services. The Company was formerly known as Baidu.com, Inc. and changed its name to Baidu, Inc. in December 2008.

According to the Plaintiff’s law firm press release, Staar Surgical Company has recently emphasized its revenue, sales growth, and market share in the Chinese market. STAAR attributed its success to its strategic partnerships, including with its customer AIER, a Chinese ophthalmology hospital group.

According to the Complaint, Alteryx, Inc. is a data analytics company that offers a subscription-based platform for customers to access, prepare, and analyze data from a multitude of sources, then deploy and share analytics at scale to make data-driven decisions.

According to the Complaint, Noble Energy, Inc. is an independent oil and natural gas exploration and production company. The Company operates a high-quality portfolio of assets onshore in the United States, offshore in the Eastern Mediterranean, and off the west coast of Africa.

According to the Complaint, Genius Brands International, Inc. is a multimedia company that licenses entertainment content for children.

According to the Complaint, Chembio Diagnostics, Inc. describes itself as a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases.

According to the Complaint, this action stems from a proposed transaction announced on July 7, 2020 (the “Proposed Transaction”), pursuant to which National General Holdings Corp. (“National General” or the “Company”) will be acquired by The Allstate Corporation and Bluebird Acquisition Corp. On July 7, 2020, National General’s Board of Directors caused the Company to enter into an agreement and plan of merger (the “Merger Agreement”) with Allstate. Pursuant to the terms of the Merger Agreement, National General’s stockholders will receive $32.00 in cash plus a special dividend equal to $2.50 in cash for each share of National General common stock they own.

According to the Complaint, Kodak is a technology company that provides hardware, software, consumables, and services to customers in commercial print, packaging, publishing, manufacturing, and entertainment.

According to the Complaint, Cabot was incorporated in 1989 and is headquartered in Houston, Texas. Cabot is an independent oil and gas company that explores for, exploits, develops, produces, and markets oil and gas properties in the U.S.

According to the Complaint, Plaintiffs allege that in violation of the Exchange Act and in further violation of their fiduciary duties, Defendants caused to be filed with the SEC the materially deficient Preliminary Proxy on July 31, 2020 in an effort to solicit stockholders to vote their Churchill shares in favor of the Proposed Transaction. The Preliminary Proxy is materially deficient and deprives Churchill stockholders of the information they need to make an intelligent, informed and rational decision of whether to vote their shares in favor of the Proposed Transaction.

According to the Complaint, MEI Pharma was founded in 2000 and is based in San Diego, California. The Company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma is a late-stage pharmaceutical company that focuses on the development of various therapies for the treatment of cancer. MEI Pharma’s clinical drug candidates include, among others, Pracinostat, an oral histone deacetylase inhibitor.

According to the Complaint, Airbus SE is a multinational aerospace corporation, operating through its Commercial Aircraft, Defense and Space, and Helicopters divisions.

According to the Complaint, GlobalSCAPE, Inc. secures and automates the movement and integration of data in, around, and outside organizations in and out of the cloud. Founded in 1996, the Company’s data exchange and integration software and cloud services are used by thousands of customers worldwide, including global enterprises, governments, and small and medium enterprises.

According to the Complaint, Rexahn Pharmaceuticals, Inc. is a biotechnology company that focuses on the development of innovative therapies to improve patient outcomes in cancers that are difficult to treat.